Preoperative Cardiology Consultation and the Incidence of Major Adverse Cardiac Events(MACE)
Launched by CHINESE PLA GENERAL HOSPITAL · Mar 13, 2025
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
Background Preoperative electrocardiogram (ECG) is one of the important methods for perioperative assessment. It can reflect the patient's cardiac condition to a certain extent and indicate the potential risk of major adverse cardiac events (MACE). When a patient has an abnormal preoperative ECG, the standard medical procedure is to consult with a cardiologist to assess cardiac risk and adjust cardiac function, thereby reducing the incidence of adverse cardiac events. However, some studies suggest that cardiology consultation may delay surgery for elderly fracture patients and that consulta...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 65 years;
- • Preoperative ECG results available.
- Exclusion Criteria:
- • Age \< 65 years;
- • Accepted cardiac or neuro surgery;
- • Second surgery within 30 days post-operation;
- • Patient refused to follow up.
About Chinese Pla General Hospital
The Chinese PLA General Hospital, a prominent military medical institution in Beijing, serves as a leading sponsor for clinical trials, focusing on advancing healthcare through innovative research and development. Renowned for its comprehensive medical services and cutting-edge research capabilities, the hospital is committed to improving patient outcomes through rigorous scientific investigation and collaboration with various stakeholders in the healthcare sector. With a multidisciplinary approach and a strong emphasis on evidence-based practices, the Chinese PLA General Hospital aims to contribute significantly to the global medical community by facilitating the development of safe and effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Trial Officials
Jingsheng Lou, PhD & MD
Principal Investigator
The First Medical Center, Chinese PLA General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported